We’re having so much fun scoring awesome deals during Black Friday and now Cyber Week. Take some of your savings and give back today, Giving Tuesday.
Consider donating to Primary Children’s Hospital today.
Ringling Bros. and Barnum & Bailey® has joined #GivingTuesday, on December 1, 2015, to support childhood cancer research at Primary Children’s Hospital. #GivingTuesday is held annually on the Tuesday after Thanksgiving to kick-off the holiday giving season and inspire people to collaborate in improving their local communities and giving back in impactful ways to the charities and causes they support.
Ringling Bros. and Barnum & Bailey® is working towards a world with more elephants and less cancer and are encouraging people to give to further groundbreaking pediatric cancer research. The research is being conducted by Dr. Joshua Schiffman who is studying elephant DNA from Ringling Bros.’ herd of Asian elephants with his team of scientists who found that elephants almost never get cancer and may hold the key to a treatment for humans.
When people donate on December 1, 2015 for #GivingTuesday to support childhood cancer research at Primary Children’s Hospital they can receive up to four Ringling Bros. circus ticket vouchers good for any Ringling Bros. show. To donate to Dr. Schiffman’s work and support Childhood Cancer Research go to the following web page on December 1, 2015 to participate in this Ringling Bros. #GivingTuesday offer.
. Donation Levels:
- $35 Donation (qualifies for 1 ticket voucher to Ringling Bros.)
- $50 Donation (qualifies for 2 ticket vouchers to Ringling Bros.)
- $65 Donation (qualifies for 3 ticket vouchers to Ringling Bros.)
- $80 Donation (qualifies for 4 ticket vouchers to Ringling Bros.)
Pediatric oncologist Dr. Joshua Schiffman and the team from Intermountain Primary Children’s Hospital, Department of Pediatrics, and the Huntsman Cancer Institute, all in Salt Lake City, Utah, are studying in conjunction with Ringling Bros. Center for Elephant Conservation’s lead veterinarian and conservation scientist to find out why there is such a low incidence of cancer in elephants, what makes this cancer resistance possible in elephants and not in humans, and how this may correlate to new treatments for pediatric cancers.
“Cancer affects so many families across this country, and unfortunately it’s becoming more common, especially among children. That’s why Ringling Bros. is dedicated to this funding effort and hopeful that Dr. Schiffman’s research will lead to a new treatment for pediatric cancer and beyond,” said Alana Feld, executive vice president and producer for Ringling Bros. and Barnum & Bailey.
Could Elephants hold the key for cancer treatments? Read the full research article here in The Journal of American Medical Association. To learn more about the research, visit RinglingElephantCenter.com and view this illustrated video about the research.